ITRS Launches Distributed Tracing to Automate Root Cause Analysis in Hybrid IT Environments
Built on OpenTelemetry, ITRS Traces deliver deep, end-to-end visibility across hybrid IT, automating root cause analysis, reducing MTTR, and proactively detecting anomalies in regulated environments.
ITRS, the global leader in real-time monitoring and observability for mission-critical, highly regulated environments, announced the release of Distributed Tracing powered by OpenTelemetry (OTel). This industry-standard, open-source approach underpins powerful new capabilities within the ITRS Analytics platform, to give enterprise IT teams deep, end-to-end visibility across microservices, APIs, containers, databases, and legacy systems, without locking them into proprietary agents or limited instrumentation.
Modern enterprise IT systems, especially in financial services, payments, and trading infrastructure, rely on fast-moving, distributed applications. When transactions span dozens of distributed services across on-prem, cloud, and containerized environments, traditional monitoring fails to deliver insight. With Distributed Tracing, ITRS customers can visualize and analyze entire request lifecycles across their technology stacks. Embracing OpenTelemetry enables ITRS customers to unify telemetry across complex hybrid architectures while remaining vendor-agnostic. This results in faster RCA, fewer escalations, and more resilient digital services. ITRS is committed to OpenTelemetry integration, and this offering complements our native telemetry pipeline capability, another key aspect of any OpenTelemetry ecosystem.
Product detail
Geneos Distributed Tracing offers out-of-the-box support for OpenTelemetry and integrates seamlessly with existing monitoring agents. Key capabilities include:
- End-to-end visibility into request paths across microservices, databases, APIs, and legacy hosts
- Real-time correlation of trace data with logs, metrics, and alerts
- Smart filtering to surface latency hotspots, service-level failures, and transaction drops
- Automated dependency mapping to contextualize incidents during peak loads or regulatory audits
- A guided tour of Distributed Tracing
By aligning trace insights with Geneos’ advanced alerting and AI-powered analytics, users can proactively detect issues before they escalate and reduce the burden of manual investigation.
Strategic context
This release represents a key milestone in ITRS’ hybrid observability roadmap and further strengthens its AIOps foundation. As organizations modernize infrastructure and adopt distributed architectures, Distributed Tracing equips them to maintain control, ensure compliance, and deliver seamless digital experiences under pressure.
“Distributed architectures unlock innovation—but they also introduce complexity and risk especially for highly regulated enterprises,” said Ryan Terpstra, CEO of ITRS. “With Distributed Tracing powered by OpenTelemetry (OTel), our customers gain the end-to-end visibility they need to diagnose issues faster, improve uptime, and keep critical services running smoothly, no matter how complex their environments become.”
ITRS is the global leader in real-time monitoring and observability for mission-critical, highly regulated environments. Trusted by 90% of Tier 1 capital markets firms and thousands of enterprises worldwide, we deliver deep, actionable insights that keep complex, hybrid IT ecosystems resilient, compliant, and always-on. Our solutions span on-prem, cloud, and containerized environments—empowering IT teams to prevent outages, accelerate root cause analysis, and optimize performance where it matters most.
Whether powering low-latency trading platforms, safeguarding digital banking, or ensuring uptime for critical web services, ITRS helps the world’s most demanding organizations stay one step ahead.
For more information go to www.itrsgroup.com. Follow us on LinkedIn: https://www.linkedin.com/company/itrsgroup/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527235228/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release
Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom